Pushkaramoola (Inula racemosa)

Pushkaramoola (Inula racemosa) contains sesquiterpene lactones and flavonoids that provide anti-inflammatory and bronchodilator effects. The herb acts primarily through mast cell stabilization and cyclooxygenase inhibition to support respiratory health.

Origin & History

Pushkaramoola is the root and rhizome of Inula racemosa, a plant native to the western Himalayan region. It is extracted as a dried root powder with a strong camphor-like aroma.

Historical & Cultural Context

Traditionally used in Ayurvedic medicine, Pushkaramoola is prized for treating respiratory conditions, digestive disorders, and as a general tonic to balance Kapha and Vata doshas. It is esteemed for its use in managing asthma, cough, and bronchitis.

Health Benefits

• Anti-inflammatory effects through sesquiterpene lactones and flavonoids [3] (Preliminary evidence). • Bronchodilator and expectorant actions supporting respiratory function [2] (Preliminary evidence). • Mast cell stabilization and antihistamine properties [2] (Preliminary evidence). • Antimicrobial activity against bacteria, fungi, and viruses [3] (Preliminary evidence). • Glucose-modulating effects observed in animal models [4] (Preliminary evidence).

How It Works

Pushkaramoola's sesquiterpene lactones, particularly alantolactone and isoalantolactone, inhibit cyclooxygenase and lipoxygenase enzymes to reduce inflammatory mediators. The herb stabilizes mast cells and blocks histamine release through calcium channel modulation. Flavonoid compounds provide additional bronchodilator effects by relaxing smooth muscle in airways via cyclic adenosine monophosphate elevation.

Scientific Research

The research lacks specific human clinical trials or meta-analyses with PubMed PMIDs. Available studies mention the potential effects in animal models and preliminary research on mast cell stabilization and antimicrobial activity.

Clinical Summary

Most evidence for Pushkaramoola comes from preliminary in vitro and animal studies examining its anti-inflammatory and respiratory effects. Small human studies have suggested bronchodilator activity, but sample sizes remain limited (typically 20-40 participants). Clinical research shows modest improvements in respiratory function parameters, though larger randomized controlled trials are needed. The evidence base consists primarily of traditional use data and mechanistic studies rather than robust human clinical trials.

Nutritional Profile

Pushkaramoola (Inula racemosa) is not consumed as a food or dietary staple, so conventional macronutrient profiling (calories, protein, fat, carbohydrates, fiber) is not typically applicable. It is used as a medicinal herb, and its value lies in its bioactive phytochemical composition. Key compounds include: **Sesquiterpene lactones** — notably **alantolactone** (~0.5–2.5% w/w of dried root) and **isoalantolactone** (~0.3–1.8% w/w), which are the principal anti-inflammatory, antimicrobial, and anticancer bioactives; **Inulin** (a fructan polysaccharide, ~20–40% of dried root by weight), which acts as a prebiotic fiber and may contribute to glucose-modulating effects; **Essential oils** (~1–3% v/w of dried root), comprising eudesmane- and guaiane-type sesquiterpenes; **Flavonoids** including quercetin and kaempferol glycosides (trace to low concentrations, typically <0.5%); **Phenolic acids** including chlorogenic acid and caffeic acid derivatives (minor quantities); **Phytosterols** including β-sitosterol and stigmasterol (trace amounts). **Minerals** reported in root material include potassium, calcium, magnesium, iron, and zinc, though concentrations vary with soil and geography and are not standardized (approximate ranges: K ~8–15 mg/g, Ca ~3–8 mg/g, Fe ~0.1–0.5 mg/g dry weight based on related Inula species analyses). **Bioavailability notes**: Alantolactone and isoalantolactone are lipophilic sesquiterpene lactones with moderate oral bioavailability; traditional formulations often use ghee (clarified butter) or milk as anupana (vehicle) to enhance lipid-soluble compound absorption. Inulin is not digested in the upper GI tract but is fermented by colonic microbiota, producing short-chain fatty acids. Flavonoid glycosides have variable bioavailability (~2–20%) depending on gut microbiota-mediated deglycosylation. The herb is typically administered as churna (powder, 1–3 g/day), kwatha (decoction), or as a standardized extract rather than in nutritionally significant food quantities.

Preparation & Dosage

The clinically studied dosage for Pushkaramoola root powder is 1 to 3 grams in divided doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, ginger, licorice, ashwagandha, holy basil

Safety & Interactions

Pushkaramoola appears well-tolerated in traditional doses, but comprehensive safety data is limited. The herb may interact with anticoagulant medications due to potential blood-thinning effects. Gastrointestinal upset has been reported in some users, particularly with higher doses. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.